Koen Iterbeke
Impact in
- Virology top 5%
- HIV Research and Treatment
- Pharmaceutical Science top 5%
Papers in
-
- Chemical Synthesis and Analysis 6
- Histone Deacetylase Inhibitors Research 2
-
- Radiopharmaceutical Chemistry and Applications 9
- Co-authors
- Dirk Tourwé (17 shared papers)Peter Bläuenstein (3 shared papers)Elisa García‐Garayoa (2 shared papers)P. August Schubiger (2 shared papers)Jan Rosier (1 shared paper)Piet Wigerinck (1 shared paper)Paul Stevens (1 shared paper)Laurent Schueller (1 shared paper)
- Journals
- Nuclear Medicine and Biology (2 papers)Nuclear Medicine Communications (2 papers)The Journal of Organic Chemistry (1 paper)Expert Review of Anti-infective Therapy (1 paper)European Journal of Pharmaceutics and Biopharmaceutics (1 paper)
- Partner nations
- BelgiumSwitzerlandUnited States
In The Last Decade
Koen Iterbeke
20 papers receiving 644 citations
Peers
Comparison fields: 5 of 69
- Virology 83
- Pharmaceutical Science 73
- Radiology, Nuclear Medicine and Imaging 230
- Oncology 182
- Infectious Diseases 123
Countries citing papers authored by Koen Iterbeke
This map shows the geographic impact of Koen Iterbeke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Koen Iterbeke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Koen Iterbeke more than expected).
Fields of papers citing papers by Koen Iterbeke
This network shows the impact of papers produced by Koen Iterbeke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Koen Iterbeke. The network helps show where Koen Iterbeke may publish in the future.
Co-authors
The 25 scholars most cited alongside Koen Iterbeke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 21 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2009 | 185 | |
| 2 | Organometallic 99mTc-aquaion labels peptide to an unprecedented high specific activity. | 1999 | 118 |
| 3 | 2001 | 81 | |
| 4 | 2002 | 76 | |
| 5 | Preclinical evaluation of a new, stabilized neurotensin(8--13) pseudopeptide radiolabeled with (99m)tc. | 2002 | 58 |
| 6 | 2014 | 40 | |
| 7 | 2000 | 22 | |
| 8 | 2003 | 20 | |
| 9 | 1999 | 14 | |
| 10 | 2015 | 11 | |
| 11 | 1999 | 11 | |
| 12 | 2000 | 10 | |
| 13 | 1998 | 6 | |
| 14 | 2001 | 6 | |
| 15 | 2003 | 3 | |
| 16 | 2003 | 3 | |
| 17 | 2001 | 1 | |
| 18 | 2001 | 1 | |
| 19 | 2000 | 1 | |
| 20 | 2000 | 1 |
About Koen Iterbeke
Koen Iterbeke is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Organic Chemistry, Infectious Diseases and Cellular and Molecular Neuroscience, having authored 21 papers that have together received 668 indexed citations. Recurring topics across this work include Radiopharmaceutical Chemistry and Applications (9 papers), Chemical Synthesis and Analysis (6 papers), HIV/AIDS drug development and treatment (3 papers), Peptidase Inhibition and Analysis (3 papers), Neuropeptides and Animal Physiology (3 papers), Cholinesterase and Neurodegenerative Diseases (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Neuroendocrine Tumor Research Advances (2 papers). The work is most often cited by research in Virology (83 citations), Pharmaceutical Science (73 citations), Radiology, Nuclear Medicine and Imaging (230 citations), Oncology (182 citations) and Infectious Diseases (123 citations). Koen Iterbeke has collaborated with scholars based in Belgium, Switzerland and United States. Frequent co-authors include Dirk Tourwé, Peter Bläuenstein, Elisa García‐Garayoa, P. August Schubiger, Jan Rosier, Piet Wigerinck, Paul Stevens, Laurent Schueller, P. Van Remoortere and Gerben van ‘t Klooster. Their work appears in journals such as Nuclear Medicine and Biology, Nuclear Medicine Communications, The Journal of Organic Chemistry, Expert Review of Anti-infective Therapy and European Journal of Pharmaceutics and Biopharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.